Dynamic Technology Lab Private Ltd Sells 7,412 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Dynamic Technology Lab Private Ltd lowered its position in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 35.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 13,326 shares of the company’s stock after selling 7,412 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in Definitive Healthcare were worth $55,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Principal Financial Group Inc. grew its position in Definitive Healthcare by 9.7% during the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock valued at $181,000 after buying an additional 3,874 shares during the period. Rhumbline Advisers boosted its stake in Definitive Healthcare by 5.2% in the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock valued at $334,000 after acquiring an additional 4,034 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of Definitive Healthcare by 27.4% during the 4th quarter. Wells Fargo & Company MN now owns 31,297 shares of the company’s stock valued at $129,000 after acquiring an additional 6,736 shares during the period. Nisa Investment Advisors LLC grew its position in shares of Definitive Healthcare by 3,652.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after acquiring an additional 6,794 shares during the period. Finally, SG Americas Securities LLC increased its stake in shares of Definitive Healthcare by 44.6% during the 4th quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after purchasing an additional 8,387 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on DH. Stephens started coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective on the stock. The Goldman Sachs Group dropped their price target on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Finally, Barclays dropped their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $5.35.

Definitive Healthcare Trading Up 4.4 %

Shares of DH opened at $2.59 on Friday. Definitive Healthcare Corp. has a twelve month low of $2.15 and a twelve month high of $7.66. The stock has a market cap of $292.44 million, a PE ratio of -0.84, a P/E/G ratio of 4.06 and a beta of 1.48. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The business’s 50-day moving average price is $3.57 and its 200-day moving average price is $4.10.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The firm had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. On average, equities analysts forecast that Definitive Healthcare Corp. will post 0.16 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.